PharmaCyte Biotech, Inc.

Insider Reports History

Reporting-owner location: Las Vegas, NV
Latest reporting-owner signature: /s/ Joshua N. Silverman, President and CEO
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for PharmaCyte Biotech, Inc.

Form 4 holding 10%+ Owner

Q/C TECHNOLOGIES, INC.

Security class: Series H Convertible Preferred Stock
Shares / value: 889,865
Estimated value
Report date: 04 Sep 2025
Price
Ownership: Direct
Underlying class: Common stock, par value $0.001 per share
Underlying amount

Form 4 holding 10%+ Owner

Q/C TECHNOLOGIES, INC.

Security class: Warrants
Shares / value: 889,865
Estimated value
Report date: 14 Nov 2025
Price
Ownership: Direct
Underlying class: Common stock, par value $0.001 per share
Underlying amount

Insider Reports Filed by PharmaCyte Biotech, Inc.

4 FEMY

FEMASYS INC

Report period: 17 Mar 2026
Transactions: 0
Transaction value: $0
Accepted by SEC: 18 Mar 2026, 17:00
Role: 10%+ Owner
Next action: Open filing details

4 TNFA

Q/C TECHNOLOGIES, INC.

Report period: 04 Sep 2025
Transactions: 2
Transaction value: $0
Accepted by SEC: 18 Nov 2025, 16:32
Role: 10%+ Owner
Next action: Open filing details

3 TNFA

MyMD Pharmaceuticals, Inc.

Report period: 23 May 2024
Transactions: 0
Transaction value: $0
Accepted by SEC: 30 May 2024, 16:05
Role: 10%+ Owner
Next action: Open filing details

3 FEMY

FEMASYS INC

Report period: 21 Nov 2023
Transactions: 0
Transaction value: $0
Accepted by SEC: 28 Nov 2023, 17:06
Role: 10%+ Owner
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .